1. Home
  2. RIOT vs MIRM Comparison

RIOT vs MIRM Comparison

Compare RIOT & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riot Platforms Inc.

RIOT

Riot Platforms Inc.

HOLD

Current Price

$15.30

Market Cap

5.2B

Sector

Technology

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$86.64

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RIOT
MIRM
Founded
2000
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RIOT
MIRM
Price
$15.30
$86.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
11
Target Price
$26.13
$95.64
AVG Volume (30 Days)
14.4M
842.5K
Earning Date
02-23-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
693.97
N/A
EPS
0.40
N/A
Revenue
$637,162,000.00
$471,794,000.00
Revenue This Year
$78.69
$53.78
Revenue Next Year
$11.24
$19.91
P/E Ratio
$37.62
N/A
Revenue Growth
103.62
53.66
52 Week Low
$6.19
$36.88
52 Week High
$23.94
$83.75

Technical Indicators

Market Signals
Indicator
RIOT
MIRM
Relative Strength Index (RSI) 55.45 69.69
Support Level $12.62 $73.82
Resistance Level $13.95 $83.75
Average True Range (ATR) 0.75 3.90
MACD 0.30 0.69
Stochastic Oscillator 76.23 98.63

Price Performance

Historical Comparison
RIOT
MIRM

About RIOT Riot Platforms Inc.

Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: